Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT04685967
Active, not recruiting Not applicable

Clinical Evaluation of a Restorative Glass Ionomer and a Bulk-fill Composite Resin

NCT04685967 · tracked via the Priya Life Science Turkey tracker
Sponsor
Hacettepe University
Phase
Not applicable
Started
2021-03-15
Last updated
2025-12-03

Condition(s) studied

Tooth Disease

Investigational drug(s) / intervention(s)

Glass ionomerBulk-fill composite

Glass ionomer: Equia Forte HT, GC, Tokyo, Japan

Bulk-fill composite: SonicFill2, Orange, CA, USA

Study summary

The clinical performance of a restorative glass ionomer and bulk-fill resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 2 approximal caries lesions, all restorations will be placed by a single clinician. All caries lesions will be removed before restoring. Cavities will be divided into two groups: a restorative glass ionomer \[Equia Forte HT, GC, Tokyo, Japan (EHT)\] and bulk-fill composite resin \[SonicFill2, Orange, CA, USA (SBF)\] All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using modified United States Public Health Service (USPHS) criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * age range will be 18 to 65 * patients should have at least 2 approximal caries lesions require restoration * healthy periodontal status * a good likelihood of recall availability Exclusion Criteria: * poor gingival health * adverse medical history * potential behavioral problems

Primary outcome measure(s)

  • Clinical performances of different restorative systems according to USPHS criteria — two years
    Two year results according to USPHS criteria

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Ankara Turkey (Türkiye)

More Hacettepe University trials in Turkey

Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients Recruiting
Effects of Rigid Taping in Acromioclavicular Joint Degeneration Recruiting
Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation Recruiting
Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms Recruiting
Ultrasound Measurement of Skin-to-Epiglottis Distance for Prediction of Difficult Airway in Adult Patients Starting soon

Other trials for the same condition

Clinical Evaluation of a Bioactive Material Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04685967 on ClinicalTrials.gov ↗ ← All trials in Turkey